New human data hints at psychedelics' potential to combat inflammationhttps://www.npr.org/2026/10/21/nx-s1-6009441/psychedelics-brain-inflammation-immune-system
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
